SE392899B - Forfarande for framstellning av pyridazinderivat med psykotrop, serskilt antidepressiv verkan - Google Patents

Forfarande for framstellning av pyridazinderivat med psykotrop, serskilt antidepressiv verkan

Info

Publication number
SE392899B
SE392899B SE7207999A SE799972A SE392899B SE 392899 B SE392899 B SE 392899B SE 7207999 A SE7207999 A SE 7207999A SE 799972 A SE799972 A SE 799972A SE 392899 B SE392899 B SE 392899B
Authority
SE
Sweden
Prior art keywords
psychotrop
procedure
special
preparation
pyridazine derivatives
Prior art date
Application number
SE7207999A
Other languages
English (en)
Swedish (sv)
Inventor
H Laborit
Original Assignee
Experimentales Et Cliniques De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Experimentales Et Cliniques De filed Critical Experimentales Et Cliniques De
Publication of SE392899B publication Critical patent/SE392899B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7207999A 1971-06-18 1972-06-16 Forfarande for framstellning av pyridazinderivat med psykotrop, serskilt antidepressiv verkan SE392899B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2873771 1971-06-18
FR7219096A FR2141697B1 (fr) 1971-06-18 1972-05-29

Publications (1)

Publication Number Publication Date
SE392899B true SE392899B (sv) 1977-04-25

Family

ID=26217112

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7207999A SE392899B (sv) 1971-06-18 1972-06-16 Forfarande for framstellning av pyridazinderivat med psykotrop, serskilt antidepressiv verkan

Country Status (13)

Country Link
US (1) US4169158A (fr)
JP (1) JPS5550943B1 (fr)
AR (1) AR192370A1 (fr)
AU (1) AU472247B2 (fr)
BE (1) BE784727A (fr)
CA (1) CA1003833A (fr)
CH (1) CH546769A (fr)
DE (1) DE2229215C2 (fr)
ES (1) ES403998A1 (fr)
FR (1) FR2141697B1 (fr)
GB (1) GB1345880A (fr)
NL (1) NL177893C (fr)
SE (1) SE392899B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2511366A1 (fr) * 1981-08-11 1983-02-18 Sanofi Sa Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2539742B1 (fr) * 1983-01-24 1986-09-05 Sanofi Sa Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central
FR2539739B1 (fr) * 1983-01-24 1985-11-22 Sanofi Sa Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant
FR2555178B1 (fr) * 1983-11-18 1986-04-18 Sanofi Sa Derives cyanes de la pyridazine ayant une action psychotrope, leur mode de preparation et les medicaments en contenant
FR2540115B1 (fr) * 1983-01-28 1985-06-07 Sanofi Sa Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions
FR2625201B1 (fr) * 1987-12-24 1990-06-15 Sanofi Sa Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant
PT93060B (pt) 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
FR2642757B1 (fr) * 1989-02-07 1991-05-24 Sanofi Sa Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
FR2642754B1 (fr) * 1989-02-07 1991-05-24 Sanofi Sa Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
EP1430033A4 (fr) * 2001-08-31 2004-12-15 Univ Northwestern Composition anti-inflammatoire et inhibitrice de la proteine kinase et methode d'utilisation
WO2006050359A2 (fr) 2004-11-02 2006-05-11 Northwestern University Composes pyridazine et methodes
ES2543813T3 (es) 2004-11-02 2015-08-24 Northwestern University Compuestos de piridazina para el tratamiento de enfermedades inflamatorias
CA2614116A1 (fr) * 2005-07-04 2007-01-11 Novo Nordisk A/S Medicaments
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
CA2650711A1 (fr) 2006-04-28 2007-11-08 Northwestern University Compositions et traitements utilisant des pyridazines et des inhibiteurs de cholinesterase
EP2015751A2 (fr) * 2006-04-28 2009-01-21 Northwestern University Sels de composés de pyridazine
WO2007127375A2 (fr) 2006-04-28 2007-11-08 Northwestern University Formulations contenant un composé de pyridazine
US8318927B2 (en) 2006-05-23 2012-11-27 High Point Pharmaceuticals, Llc 6-(4-cyclopropylpiperazin-1-yl)-2′-methyl-[3, 4′]-bipyridine and its uses as a medicament
CN102295606A (zh) 2006-05-29 2011-12-28 高点制药有限责任公司 合成3-（1，3-苯并间二氧杂环戊烯-5-基）-6-（4-环丙基哌嗪-1-基）-哒嗪的方法及其适用的中间体
EP2014656A3 (fr) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC Nouveaux antagonistes d'hétéocycliques h3
US8461389B2 (en) 2008-04-18 2013-06-11 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) * 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
KR102695378B1 (ko) 2018-01-23 2024-08-16 인스티튜트 구스타브 루시 종양 성장을 감소시키기 위한 미나프린의 용도

Also Published As

Publication number Publication date
FR2141697A1 (fr) 1973-01-26
DE2229215C2 (de) 1984-09-06
NL7208355A (fr) 1972-12-20
CA1003833A (en) 1977-01-18
CH546769A (fr) 1974-03-15
US4169158A (en) 1979-09-25
BE784727A (fr) 1972-10-02
ES403998A1 (es) 1975-06-01
NL177893C (nl) 1985-12-16
GB1345880A (en) 1974-02-06
AU472247B2 (en) 1973-12-20
AU4350072A (en) 1973-12-20
FR2141697B1 (fr) 1976-09-17
AR192370A1 (es) 1973-02-14
JPS5550943B1 (fr) 1980-12-20
DE2229215A1 (de) 1973-01-25
NL177893B (nl) 1985-07-16

Similar Documents

Publication Publication Date Title
SE392899B (sv) Forfarande for framstellning av pyridazinderivat med psykotrop, serskilt antidepressiv verkan
SE393800B (sv) Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt
SE415761B (sv) Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE405477B (sv) Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE401673B (sv) Forfarande for framstellning av 2-substituerade 5-sulfamyl-bensoesyror med plasmalipidsenkande verkan
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE397827B (sv) Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
SE393982B (sv) Sett att framstella dihydrokinolinderivat med antioxiderande verkan
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
NO149775C (no) Analogifremgangsmaate for fremstilling av fenyl-pyridylamin-derivater med antidepressiv virkning
SE409206B (sv) Forfarande for framstellning av kinoxalindionderivat med hypnotisk verkan
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
SE380796B (sv) Forfarande for framstellning av cyklopentanderivat
SE394429B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan
SE389108B (sv) Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan
SE383738B (sv) Forfarande for framstellning av sulfamoyl-bensensulfonamider med terapeutiska egenskaper
SE409866B (sv) Forfarande for framstellning av adenosinderivat
BE807842Q (fr) Preparation de derives de quinoxaline-2-carboxamides